Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Ann Emerg Med. 2019 Apr 5;74(4):512–520. doi: 10.1016/j.annemergmed.2019.02.017

Table 4.

Use of Additional Healthcare Resources

Outcome variable Ibuprofen + placebo (n=80) Ibuprofen + baclofen (n=80) Ibuprofen + metaxalone (n=80) Ibuprofen+ tizanidine (n=80)
Visited any healthcare provider after ED visit 12 (16%) 7 (9%)3 5 (7%)4 9 (12%)5
 Subsequent ED visit 2 2 1 3
 Primary care 8 1 3 4
 MD specialist1 1 2 1 2
 Physical therapy 0 1 0 0
 Complementary therapy2 1 0 0 0
missing 7 1 4 4
1.

Spine surgeon, pain management

2.

Massage

3.

95%CI for the 8% rounded difference between the ibuprofen+ placebo arm and the ibuprofen+ baclofen arm: −3, 18%

4.

95%CI for the 10% rounded difference between the ibuprofen+ placebo arm and the ibuprofen+ metaxalone arm: 0, 20%

5.

95%CI for the 5% rounded difference between the ibuprofen+ placebo arm and the ibuprofen+ tizanidine arm: −7, 16%